880-881 / 1578
‘Ultracentral’ tumors: non-SABR results
Tekatli, H, JTO 2016
47 consecutive cases of NSCLC (2010-2015)
Median age: 77.5 yrs; WHO PS ≥2 in 49%
Median OS 15.9 months, 3-year survival 20.1%
No isolated local recurrences
21%
“
possible
” (n=2)
or
“
likely
” (n=8)
treatment-related
deaths. Fatal pulmonary hemorrhage in 15%